We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Studies Confirm Effectiveness of Stereotactic Neurosurgery

By MedImaging International staff writers
Posted on 02 May 2017
Print article
Image: The Leksell Gamma Knife Icon, a minimally invasive stereotactic neurosurgery system (Photo courtesy of Elekta).
Image: The Leksell Gamma Knife Icon, a minimally invasive stereotactic neurosurgery system (Photo courtesy of Elekta).
New studies have confirmed the clinical effectiveness of a minimally invasive stereotactic neurosurgery system used to treat brain cancer, other non-cancerous brain tumors, and neurological conditions in patients.

The medical imaging systems provider also showcased a new stereotactic neurosurgery system intended for target localization, and coordinate referencing in precision neurosurgery.

The Leksell Gamma Knife developed by Elekta was featured in more than 15 scientific presentations at the annual meeting of the American Association of Neurological Surgeons (AANS) in Los Angeles, California, in the US, in April 2017. The head frame of the new Leksell Vantage Stereotactic system is made from a novel epoxy composite material designed to improve the speed, imaging quality, and patient comfort during neurosurgery procedures.

The new Leksell Vantage system is pending 510(k) clearance by US Food and Drug Administration, but received CE (Conformité Européenne) Mark clearance in March 2017, and will now be put into clinical practice in Europe for the first time in hospitals in France, the Netherlands, the UK, and Sweden.

VP of the Neuroscience portfolio at Elekta, Jesper Söderqvist, said, "Our Leksell Stereotactic System has been helping clinicians achieve outstanding patient outcomes for more than 60 years, and Vantage improves upon this gold standard platform to deliver uncompromising accuracy in stereotactic imaging and treatment. With potential for faster imaging, more efficient workflow, reduced artifacts and a better overall user experience, Leksell Vantage is a welcome advancement for physicians and their patients."

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound System
Voluson Signature 18
Ultrasound Doppler System
Doppler BT-200
New
Pre-Op Planning Solution
Sectra 3D Trauma

Print article

Channels

MRI

view channel
Image: Diamond dust offers a potential alternative to the widely used contrast agent gadolinium in MRI (Photo courtesy of Max Planck Institute)

Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans

Gadolinium, a heavy metal used for over three decades as a contrast agent in medical imaging, enhances the clarity of MRI scans by highlighting affected areas. Despite its utility, gadolinium not only... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more